Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesenchymal Tumor”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Early research (Phase 1)Study completedNCT01207193
What this trial is testing

Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation

Who this might be right for
Bone Cyst
Royan Institute 6
Not applicableLooking for participantsNCT07066228
What this trial is testing

Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Who this might be right for
Defective Composite RestorationsBone CystsBone Defect+1 more
The First Affiliated Hospital of Xinxiang Medical College 30
Testing effectiveness (Phase 2)WithdrawnNCT02766842
What this trial is testing

Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)

Who this might be right for
Mesenchymal TumorAutoimmune PancreatitisLymphoma+1 more
Johns Hopkins University
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Not applicableStudy completedNCT02579460
What this trial is testing

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

Who this might be right for
Barrett's EsophagusGastroesophageal Reflux Disease
Dallas VA Medical Center 15
Early research (Phase 1)Study completedNCT02509156
What this trial is testing

Stem Cell Injection in Cancer Survivors

Who this might be right for
Cardiomyopathy Due to Anthracyclines
The University of Texas Health Science Center, Houston 46
Large-scale testing (Phase 3)UnknownNCT00379457
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

Who this might be right for
Sarcoma
European Paediatric Soft Tissue Sarcoma Study Group 600
Large-scale testing (Phase 3)Study completedNCT00002995
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 483
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)WithdrawnNCT03147976
What this trial is testing

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
NantPharma, LLC
Early research (Phase 1)Ended earlyNCT04982224
What this trial is testing

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

Who this might be right for
Advanced NSCLC
Regeneron Pharmaceuticals 30
Not applicableUnknownNCT01927354
What this trial is testing

Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.

Who this might be right for
Head-and-Neck Squamous Cell Carcinoma
National Taiwan University Hospital 100
Not applicableWithdrawnNCT02022904
What this trial is testing

Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology

Who this might be right for
Prostate Cancer
Duke University
Early research (Phase 1)UnknownNCT03874572
What this trial is testing

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

Who this might be right for
Xerostomia Due to RadiotherapyHyposalivationXerostomia+6 more
Rigshospitalet, Denmark 10
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more
St. Jude Children's Research Hospital 139
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Testing effectiveness (Phase 2)WithdrawnNCT02503280
What this trial is testing

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

Who this might be right for
Chronic Ischemic Left Ventricular DysfunctionMyocardial Infarction
Joshua M Hare
Testing effectiveness (Phase 2)Study completedNCT00136903
What this trial is testing

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Vs Host Disease
Mesoblast, Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06669117
What this trial is testing

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

Who this might be right for
Solid TumorMET Alteration
Pierre Fabre Medicament 140
Load More Results